CLU and amyotrophic lateral sclerosis: In fact, clusterin levels in both cerebrospinal fluid (CSF) and plasma have been investigated for other neurodegenerative diseases and a recent mass spectrometry analysis of plasma from patients with ALS showed that clusterin levels were able to distinguish between non‐neurological controls and cognitively impaired ALS patients 24, 25.